Abstract

Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding

Author(s): Anderson Derick

Issue: Jan/Feb 2007 - Pediatric Patients

Page(s): 56-58

Download in electronic PDF format for $75
  • Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding Page 1
  • Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding Page 2
  • Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding Page 3

Abstract

Patient care within the US healthcare system is changing constantly, as are the roles of healthcare practitioners, including pharmacists. For over 30 years, pharmacists have promoted the concept of clinical pharmacy, which places pharmacists in a central role in patient medication management. The goal is to allow the pharmacist to become a vital part of treatment planning by individualizing patients’ therapeutic regimens. The Collaborative Drug Therapy Management agreement is a step toward that goal. The combination of drug therapy management and compounding pharmacy can be powerful in meeting patients’ specific needs.

Related Keywords

  • CDTM, CLINICAL PHARMACY, COLLABORATIVE HEALTH CARE, COLLABORATIVE DRUG THERAPY MANAGEMENT, PHYSICIAN, COMPOUNDING, PHARMACY

Related Categories

  • BUSINESS
  • LEGAL
  • PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2007
Pg. 56-58
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding
Author(s): Anderson Derick
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2016
Pg. 367-374
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Author(s): Kochanowska-Karamyan Anna J
Jan/Feb 2018
Pg. 7-16
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Sep/Oct 2008
Pg. 414-418
Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers
Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Jan/Feb 2014
Pg. 6-12
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jul/Aug 2008
Pg. 329-333
Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature
Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 95-102
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Author(s): Yoch Doug
Jul/Aug 2015
Pg. 295-300
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024
Pg. 111-116
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2014
Pg. 101-111
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective
Author(s): Timko Robert J, Crooker Philip EM
Nov/Dec 2015
Pg. 453-463
Applying Quality of Design Concepts to Pharmacy Compounding
Author(s): Timko Robert J
Jan/Feb 2017
Pg. 4
PreScription: Compounding Pharmacy Issues for 2017
Author(s): Allen Loyd V Jr
Sep/Oct 2014
Pg. 358-364
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy
Author(s): Palma Elisabetta, Bufarini Celestino
Sep/Oct 2014
Pg. 379-380
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Author(s): Blankenship Cynthia E
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
May/Jun 2016
Pg. 202-206
Does Your Drug Expertise Include Clinical Pharmaceutics?
Author(s): Newton David W
Mar/Apr 2018
Pg. 108-121
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Jan/Feb 2004
Pg. 65-72
Metro Atlanta Board - Certified Specialists' Attitudes Toward Compounding Pharmacy
Author(s): Greenburg Aimee R, Barnett Candace W